Augmentation therapy with tandospirone citrate in vascular depression patients with mild cognitive impairment: A prospective randomized clinical trial

Tandospirone, a Partial 5-HT1A Receptor Agonist, Administered Systemically or Into Anterior Cingulate Attenuates Repetitive Behaviors in Shank3B Mice

(2020) Jeffrey T Dunn et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Plasma serotonin levels are associated with antidepressant response to SSRIs

(2019) Amanda Holck et al.   JOURNAL OF AFFECTIVE DISORDERS

A controlled study of the efficacy and safety of tandospirone citrate combined with escitalopram in the treatment of vascular depression: A pilot randomized controlled trial at a single-center in China

(2019) Hongbin Chen et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Platelet serotonin and serotonin transporter as peripheral surrogates in depression and anxiety patients

(2018) Xiaoyin Zhuang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Effects of tandospirone augmentation in major depressive disorder patients with high anxiety: A multicenter, randomized, parallel-controlled, open-label study

(2018) Jingyu Lin et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Perspectives on the Management of Vascular Depression

(2018) Warren D. Taylor et al.   AMERICAN JOURNAL OF PSYCHIATRY

Dopamine System Dysregulation in Major Depressive Disorders

(2017) Pauline Belujon et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Vascular depression consensus report – a critical update

(2016) Howard J. Aizenstein et al.   BMC Medicine

TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics

(2016) M Gupta et al.   MOLECULAR PSYCHIATRY

The serotonin 5-HT1A receptor agonist tandospirone improves executive function in common marmosets

(2015) Satoko Baba et al.   BEHAVIOURAL BRAIN RESEARCH

Not only serotonergic system, but also dopaminergic system involved in albiflorin against chronic unpredictable mild stress-induced depression-like behavior in rats

(2015) Jingjing Song et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies

(2013) Breno S. Diniz et al.   BRITISH JOURNAL OF PSYCHIATRY

Traumatic Brain Injury-Induced Cognitive and Histological Deficits Are Attenuated by Delayed and Chronic Treatment with the 5-HT1A-Receptor Agonist Buspirone

(2012) Adam S. Olsen et al.   JOURNAL OF NEUROTRAUMA

Role of Somatodendritic and Postsynaptic 5-HT1A Receptors on Learning and Memory Functions in Rats

(2012) Saida Haider et al.   NEUROCHEMICAL RESEARCH

White matter changes in late-life depression: A diffusion tensor imaging study

(2011) Sean J. Colloby et al.   JOURNAL OF AFFECTIVE DISORDERS

F15599, a preferential post-synaptic 5-HT1A receptor agonist: Activity in models of cognition in comparison with reference 5-HT1A receptor agonists

(2010) Ronan Depoortère et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Does the Suicide Assessment Scale predict risk of repetition? A prospective study of suicide attempters at a hospital emergency department

(2010) M. Waern et al.   EUROPEAN PSYCHIATRY

A delayed and chronic treatment regimen with the 5-HT1A receptor agonist 8-OH-DPAT after cortical impact injury facilitates motor recovery and acquisition of spatial learning

(2008) Jeffrey P. Cheng et al.   BEHAVIOURAL BRAIN RESEARCH

The role of 5-HT1A receptors in learning and memory

(2008) Sven Ove Ögren et al.   BEHAVIOURAL BRAIN RESEARCH

Does stimulation of 5-HT1A receptors improve cognition in schizophrenia?

(2008) Herbert Y. Meltzer et al.   BEHAVIOURAL BRAIN RESEARCH

The Essen Stroke Risk Score Predicts Recurrent Cardiovascular Events

(2008) Christian Weimar et al.   STROKE